Cationic amphiphile micellar complexes
AssigneeGenzyme Corporation
InventorsJennifer D. Tousignant, Simon J. Eastman, Edward R. Lee, Ronald K. Scheule, Seng H. Cheng, J. Nietupski, Quiming Chu, John Marshall
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenzyme Corporation
InventorsJennifer D. Tousignant, Simon J. Eastman, Edward R. Lee, Ronald K. Scheule, Seng H. Cheng, J. Nietupski, Quiming Chu, John Marshall
Estimating the term…
The effective introduction of foreign genes and other biologically active molecules into targeted mammalian cells is a challenge still facing those skilled in the art. Gene therapy, for example, requires successful transfection of target cells in a patient. The present invention relates to novel micellar complexes of cationic amphiphilic compounds that facilitate delivery of biologically active molecules to the targeted cells of a mammal. The novel micellar complexes are comprised of a cationic amphiphile, a biologically active molecule, a derivative of polyethylene glycol (PEG), and optionally, a co-lipid. A further aspect of the invention is the use of targeting agents in any of the methods that effectuate the delivery of biologically active molecules into the cells of mammals. A targeting agent is usually any molecule, peptide sequence, or large protein that preferentially targets or binds to specific mammalian celis.
A method of making micellar complexes comprising:
A method of making micellar complexes according to claim 4, wherein said at least one cationic lipid and said DNA are present in a lipid:DNA ratio of 1:8.
A method of delivering a biologically active molecule to a cell of a mammal comprising contacting said cell with a composition comprising a micellar complex, wherein said micellar complex comprises:
A micellar complex comprising:
Dependencies are inferred from the claim text.